PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 172 filers reported holding PRECIGEN INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116 | +33.3% | 81,534 | +7.9% | 0.00% | – |
| Q2 2023 | $87 | +22.5% | 75,534 | +12.9% | 0.00% | – |
| Q1 2023 | $71 | -4.1% | 66,909 | +37.5% | 0.00% | – |
| Q4 2022 | $74 | -99.9% | 48,659 | -5.0% | 0.00% | -100.0% |
| Q3 2022 | $109,000 | +38.0% | 51,204 | -13.0% | 0.00% | – |
| Q2 2022 | $79,000 | -41.5% | 58,889 | -8.0% | 0.00% | -100.0% |
| Q1 2022 | $135,000 | -40.0% | 63,990 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $225,000 | -36.1% | 60,515 | -14.2% | 0.00% | -50.0% |
| Q3 2021 | $352,000 | -20.2% | 70,552 | +4.2% | 0.00% | 0.0% |
| Q2 2021 | $441,000 | +14.8% | 67,702 | +21.3% | 0.00% | 0.0% |
| Q1 2021 | $384,000 | -25.7% | 55,803 | +10.2% | 0.00% | -33.3% |
| Q4 2020 | $517,000 | +98.1% | 50,652 | -32.1% | 0.00% | +50.0% |
| Q3 2020 | $261,000 | -25.6% | 74,582 | +6.0% | 0.00% | -33.3% |
| Q2 2020 | $351,000 | +44.4% | 70,357 | -1.7% | 0.00% | +50.0% |
| Q1 2020 | $243,000 | – | 71,582 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |